MAP kinase p38 and its relation to T cell anergy and suppressor function of regulatory T cells

被引:21
作者
Adler, Henric S. [1 ]
Steinbrink, Kerstin [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Dermatol, D-55131 Mainz, Germany
关键词
regulatory T cells; tolerogenic dendritic cells; cell cycle; anergy; p27(Kip1); MAP kinases; p38;
D O I
10.4161/cc.7.2.5312
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Diverse regulatory T cell populations (Treg) are important for the control of self tolerance and immune homeostasis. These include naturally occurring CD4(+) CD25(+) Treg (nTreg) and induced Treg (iTreg). Tolerogenic dendritic cells, modulated by IL-10, are able to convert peripheral T cells into iTreg. These are anergic and characterized by a G(1) cell cycle arrest, dependent on elevated levels of the cdk inhibitor p27(Kip1). Novel data revealed a distinct pattern of MAP kinase activation in iTreg different from clonal T cell anergy, with enhanced activation of the p38-MAPKAP-K2/3 pathway. p38 is involved in cell cycle control and its activity is a prerequisite for the induction and maintenance of the anergic state in iTreg. Inhibition of p38 leads to down regulation of p27(Kip1), cell cycle progress and loss of regulatory T cell function. Here, we discuss these data in light of the role of p38 and p27(Kip1) in T cell activation, anergy induction and cell cycle control.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 80 条
[61]   MAP-kinase signaling pathways in T cells [J].
Rincón, M .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (03) :339-345
[62]   Opposing roles for the cyclin-dependent kinase inhibitor p27kip-1 in the control of CD4+ T cell proliferation and effector function [J].
Rowell, EA ;
Walsh, MC ;
Wells, AD .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3359-3368
[63]   The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade [J].
Rowell, Emily A. ;
Wang, Liqing ;
Hancock, Wayne W. ;
Wells, Andrew D. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (08) :5169-5176
[64]   JNK2 - A negative regulator of cellular proliferation [J].
Sabapathy, K ;
Wagner, EF .
CELL CYCLE, 2004, 3 (12) :1520-1523
[65]  
Schafer PH, 1999, J IMMUNOL, V162, P7110
[66]   AP-1 as a regulator of cell life and death [J].
Shaulian, E ;
Karin, M .
NATURE CELL BIOLOGY, 2002, 4 (05) :E131-E136
[67]   Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest [J].
Smalley, KSM ;
Eisen, TG .
MELANOMA RESEARCH, 2002, 12 (03) :187-192
[68]   Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins [J].
Steinbrink, K ;
Paragnik, L ;
Jonuleit, H ;
Tüting, T ;
Knop, J ;
Enk, AH .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (09) :437-445
[69]  
Steinbrink K, 1997, J IMMUNOL, V159, P4772
[70]   Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells [J].
Steinbrink, K ;
Jonuleit, H ;
Müller, G ;
Schuler, G ;
Knop, J ;
Enk, AH .
BLOOD, 1999, 93 (05) :1634-1642